₹80.85
₹-0.05 (-0.06%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹59 Cr
P/E
-27.00
ROE
-30.18%
ROCE
-32.45%
About Novelix Pharmaceuticals Ltd
Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities.
Founded
1994
CEO
N/A
Employees
8
HQ
Hyderabad, Telangana
About Novelix Pharmaceuticals Ltd
Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities.
Founded:1994
CEO:N/A
Employees:8
HQ:Hyderabad, Telangana
Finished Products
1Sales
₹29.62Cr2Sales of Shares
₹5.32Cr3Interest Income
₹0.22Cr4Sale of Investments
₹0.06Cr5Dividend
₹0.00CrRaw Materials
1Purchases
₹33.07Cr2Purchase of Securities
₹0.37CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹92
52W Low
₹38
Volume894
Avg VolumeN/A
Beta0.47
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-27.00x
Valuation
P/B Ratio
3.24x
Valuation
EPS
₹-1.50
Valuation
Dividend Yield
0.00%
Valuation
ROE
-30.18%
Profitability
ROCE
-32.45%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharma Business
+74.1%85.7%
₹7.85 Cr
Trading in Shares
-23.2%8.3%
₹0.76 Cr
Financial Activity
-9.1%3.3%
₹0.3 Cr
Investment Activity
+2400.0%2.7%
₹0.25 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.14x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-6.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.